TrialThe journals of gerontology. Series A, Biological sciences and medical sciences2017

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Bryon A Tompkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.